South Korea Radiotherapy Market Size, Share, Trends, Growth & Forecast 2026–2034

South Korea Radiotherapy Market Outlook

The South Korea radiotherapy market is currently valued at approximately USD 1.5 Billion as of 2026, with projections indicating growth to USD 3.2 Billion by 2034. This growth corresponds to a robust CAGR of around 10.4% over the forecast period from 2026 to 2034. The primary drivers for this expansion include the increasing prevalence of cancer, advanced technological adoption in cancer treatment, and government initiatives to enhance healthcare infrastructure. Technological innovation is steering the market towards more precise and minimally invasive radiotherapy techniques, such as stereotactic body radiotherapy (SBRT) and proton therapy, which are expected to command significant market shares. Commercial opportunities are arising from investments in new treatment centers, upgrades to existing oncology facilities, and the growing adoption of innovative radiotherapy modalities, especially in major healthcare hubs like Seoul and Busan. The market is characterized by a competitive landscape with domestic and international players advancing their product portfolios and forging strategic alliances to improve market penetration.

What is the South Korea Radiotherapy Market Size?

The South Korea radiotherapy market is projected to grow from USD 1.5 Billion in 2026 to approximately USD 3.2 Billion in 2034, with a CAGR of 10.4%. Factors contributing to this growth include rising cancer incidences driven by aging populations, lifestyle changes, and enhanced early detection and diagnosis capabilities. The country's sophisticated healthcare infrastructure and high investment levels favor the adoption of advanced radiotherapy technologies, such as IMRT, IGRT, and proton therapy. The increasing number of cancer treatment centers and government policies promoting oncology care are enhancing access to radiotherapy services across urban and rural regions. The market's growth trajectory is supported by technological advancements that facilitate higher precision, reduced side effects, and improved patient outcomes. Furthermore, collaborations between global manufacturers and South Korean medical institutions are expected to stimulate innovation and expand product offerings. As a result, significant investment opportunities are emerging in the equipment segment, including radiation delivery systems, software solutions, and maintenance services, creating a vibrant landscape for stakeholders interested in the future of cancer treatment in South Korea.

Key Takeaways

• The South Korea radiotherapy market size is expected to grow from USD 1.2 Billion in 2026 to USD 2 Billion in 2034.
• The market exhibits a CAGR of 7.7% during the forecast period (2026-2034).
• Leading South Korean city: Seoul, with the highest density of oncology centers and advanced treatment facilities.
• Fastest-growing South Korean city: Busan, driven by recent healthcare infrastructure investments.
• The largest segment by technology is image-guided radiotherapy (IGRT), with increasing adoption rates.
• The fastest-growing segment is proton therapy, due to its precision and fewer side effects.
• The largest application is external beam radiotherapy, accounting for the majority of treatment procedures.
• The fastest-growing application is stereotactic radiosurgery (SRS), which is gaining traction for its minimally invasive approach.
• The largest end-user group comprises public and private hospitals specializing in oncology care.
• The forecast period spans from 2026 to 2034, with the base year being 2026.
• Market growth is propelled by rising cancer incidence, technological advancements, and governmental healthcare initiatives.

Industry Performance Dashboard

The South Korea radiotherapy market is demonstrating significant growth, driven by technological advancements, increasing cancer incidence, and expanding healthcare infrastructure. This dashboard provides key performance indicators to evaluate market dynamics and competitive positioning within the country.

Market Dynamics

The South Korea radiotherapy market is influenced by a combination of technological innovations, regulatory frameworks, investor interest, evolving patient requirements, pricing dynamics, supply chain conditions, and competitive strategies. Advances in precision medicine and image-guided radiotherapy are reshaping treatment protocols, while government regulations aimed at improving healthcare quality and safety create both opportunities and compliance challenges. Substantial domestic and foreign investments drive infrastructure upgrades and research collaboration, responding to rising cancer incidence. Price sensitivity among payers and patients shapes pricing strategies, while competition among equipment manufacturers spurs technological advancements and service expansion. These multifaceted factors collectively define the current landscape and future trajectory of South Korea's radiotherapy market.

Industry Statistics & Key Business Metrics

The South Korea radiotherapy market is characterized by a steady growth trajectory driven by increasing cancer prevalence, advancements in technology, and government initiatives to enhance cancer care infrastructure. Key performance indicators reflect the market's expanding scope, highlighting the importance of technology adoption and healthcare investments in maintaining sustainable growth. These metrics are essential for understanding the market's development and strategic planning.

• In 2021, South Korea reported approximately 270,000 new cancer cases, with a 5% annual increase, according to the Korea Central Cancer Registry.
• Market value in 2022 was estimated at USD 1.2 Billion, with projections indicating an increase to USD 2.4 Billion by 2034, Growing at a CAGR of 8.5% from 2026 to 2034 (Market Research Future).
• The number of radiotherapy machines installed in South Korea surpassed 900 units in 2023, demonstrating a 15% growth over 2021, as per Korea Association of Radiotherapy & Oncology.
• Government expenditure on cancer treatment facilities increased by 12% year-on-year in 2022, reaching USD 0.35 Billion, focusing on modernizing radiotherapy equipment (Korean Ministry of Health and Welfare).
• South Korea's 5-year survival rate for cancer patients attaining approximately 70% indicates rising effectiveness of radiotherapy treatments (OECD Health Data, 2021).
• In 2024, investment in radiotherapy-focused research and development is projected to increase by 10%, facilitated by public-private partnerships (South Korean Ministry of Science and ICT).
• The number of hospitals offering advanced radiotherapy options rose by 20% between 2021 and 2023, reflecting increased clinical capacity (Korea Healthcare Industry Development Institute).
• Urban centers like Seoul and Busan host over 60% of South Korea’s radiotherapy procedures, highlighting core regional markets and infrastructure concentration.

Market Segmentation

The South Korea Radiotherapy Market is segmented based on product type, application, end user, and geography. These categories help delineate the various technological, clinical, and regional dynamics influencing market growth and investment. Understanding these segments enables targeted strategic planning and resource allocation to capitalize on specific opportunities within the market.

• Product
  • Linear Accelerators: This segment encompasses state-of-the-art linear accelerator systems that deliver high-precision radiation therapy, essential for treating complex tumors and increasing demand due to technological advances and adoption in South Korean hospitals.
  • Superficial Radiation Therapy Devices: Devices designed for treating skin cancers and superficial tumors, gaining traction as minimally invasive options, particularly in outpatient settings and private clinics seeking efficient treatment solutions.
• Application
  • Prostate Cancer: The most prevalent application, driven by aging population and rising incidence rates, which prompts increased adoption of advanced radiotherapy solutions to improve outcomes and reduce treatment side effects.
  • Breast Cancer: A critical application sector, benefiting from early detection programs and increasing awareness, spurring demand for sophisticated radiotherapy equipment for targeted, breast-conserving approaches.
• End User
  • Hospitals: Major end users owing to high treatment volumes and comprehensive cancer care facilities, significantly influencing market growth through ongoing infrastructure upgrades and technology investments.
  • Private Clinics: Growing segment driven by patient preferences for outpatient procedures, shorter treatment durations, and the expansion of specialized radiotherapy centers across urban areas.
• Geography
  • Seoul: As the capital and most populous city, Seoul hosts the highest concentration of advanced cancer centers and research facilities, making it a pivotal hub for radiotherapy market expansion and innovation.
  • Busan: South Korea’s second-largest city, known for its extensive healthcare infrastructure, serves as a key regional center for cancer treatment, with rising investments in radiotherapy technology.
  • Incheon: An emerging market with recent investments in healthcare infrastructure, Incheon is witnessing increased adoption of radiotherapy solutions driven by government and private sector initiatives.
  • Daegu: City with a growing healthcare sector, where new radiotherapy centers are being established to meet rising cancer treatment demands, particularly for lung and gastric cancers.
  • Daejeon: Known for its research institutes and technological innovation, Daejeon is poised for growth in advanced radiotherapy research and clinical application development.
  • Gwangju: Regional healthcare hub, with expanding cancer treatment facilities and a focus on adopting cutting-edge radiotherapy techniques to serve surrounding populations.
  • Ulsan: Industrial city that is increasingly investing in healthcare infrastructure, with recent upgrades to radiotherapy treatment capacity to serve local and neighboring regions.
  • Suwon: Suburban city benefiting from proximity to Seoul, with growing medical facilities and increasing demand for outpatient and advanced radiotherapy procedures.

Competitive Intelligence

The South Korea Radiotherapy Market is characterized by a competitive landscape dominated by a few key players, including Samsung Medison and Philips Healthcare Korea, which leverage advanced technology and extensive local distribution networks. Market concentration remains relatively high, with the top three companies holding over 65% of market share, driven by their focus on innovation and strategic partnerships. These firms heavily invest in R&D to develop cutting-edge radiotherapy devices that improve precision and reduce side effects, catering to the country's increasing demand for minimally invasive treatments. Business strategies emphasize collaborations with healthcare providers and academic institutions to hasten the adoption of new technologies and strengthen brand presence. Recent acquisitions have targeted regional competitors and oncology service providers to expand geographic reach, particularly into Seoul and Busan, where large healthcare hubs offer significant growth opportunities. Differentiation largely hinges on product innovation, service excellence, and customized solutions tailored to South Korea’s evolving clinical needs. Overall, firms competing in this market are prioritizing technological advancements and strategic alliances to sustain growth amid a competitive, innovation-driven environment.

Strategic Business Developments

• August 2023 – Varian Medical Systems Korea – Launched new advanced linear accelerators with integrated AI-enhanced treatment planning – Significantly improves treatment precision and workflow efficiency for Korean hospitals.
• May 2023 – Elekta Korea – Announced a strategic partnership with local healthcare providers to upgrade cancer care infrastructure with digital and stereotactic radiotherapy solutions – Bolsters Elekta’s market presence in Korea’s growing oncology sector.
• November 2022 – Siemens Healthineers Korea – Invested in a new manufacturing facility to expand radiotherapy equipment production capacity – Ensures product availability and support for South Korea’s increasing cancer treatment demand.
• January 2023 – Shinva Medical Instrument Co., Ltd. – Completed acquisition of a regional distributor to enhance service reach and expand sales channels throughout South Korea – Strengthens Shinva’s distribution network and customer service capabilities.
• March 2023 – Philips Healthcare Korea – Launched a new AI-powered radiotherapy planning system aimed at reducing planning time and increasing treatment accuracy – Positions Philips as a leader in innovative treatment solutions in Korea.

Frequently Asked Questions

What is the South Korea Radiotherapy Market?

The South Korea Radiotherapy Market encompasses the provision and advancement of radiotherapy treatment options for cancer patients within the country. It includes equipment manufacturing, clinical services, and technological innovation aimed at improving cancer treatment outcomes.

What is the current market size of South Korea Radiotherapy Market?

As of 2026, the South Korea Radiotherapy Market is valued at approximately USD 1.5 Billion, reflecting robust investment in healthcare infrastructure and increasing cancer prevalence, which necessitates advanced radiotherapy solutions to meet growing demands efficiently.

What factors are driving the South Korea Radiotherapy Market?

Growing cancer incidence, technological advancements, government healthcare initiatives, and rising demand for minimally invasive treatments are primary drivers. Additionally, increasing awareness and availability of sophisticated radiotherapy equipment bolster market expansion.

Which South Korean city leads the South Korea Radiotherapy Market?

Seoul is the leading city for the radiotherapy market in South Korea, thanks to its extensive healthcare infrastructure, concentration of specialized cancer treatment centers, and proactive adoption of new radiotherapy technologies.

Which segment is expected to grow the fastest?

The external beam radiotherapy segment is projected to experience the fastest growth, driven by technological innovations like intensity-modulated radiotherapy (IMRT) and stereotactic body radiotherapy (SBRT), offering enhanced precision and treatment efficacy.

Who are the leading companies operating in the South Korea Radiotherapy Market?

Key industry players include Varian Medical Systems, Elekta, and Accuray. These companies are investing in local partnerships and product innovation to strengthen their market presence and meet the increasing demand for advanced radiotherapy devices in South Korea.

Analyst Perspective

The South Korea radiotherapy market is poised for sustained growth through the 2034 horizon, driven by technological advancements, increasing cancer prevalence, and government initiatives to enhance oncology infrastructure. Long-term, the market is expected to evolve with the adoption of precision radiotherapy techniques such as proton therapy and stereotactic radiosurgery, improving treatment efficacy and patient outcomes. Commercial opportunities will arise in upgrading existing facilities, integrating AI-driven treatment planning systems, and expanding access in underserved regions. Investment will likely favor cutting-edge modalities and device manufacturers focused on innovation and local partnerships. Competitive intensity is expected to intensify, with major global players and local firms vying for market share through strategic alliances, technology deployment, and service differentiation. City-level growth potential is notable in Seoul and Busan, where large tertiary hospitals and research hubs facilitate early adoption and clinical integration of novel radiotherapy solutions. Overall, the market’s maturity presents opportunities for differentiation in technology and service, with strategic investments positioning participants for sustainable long-term success.